Financial Statement Analysis of Pharmaceuticals in Pakistan
Final Project
Profitability Ratios’ Analysis of Pharmaceuticals in same industry for FY 2008-10
Sanofi-Aventis
Ferozsons
Abbott
A REPORT
SUBMITTED TO THE DEPARTMENT OF MANAGEMENT SCIENCES,
VIRTUAL UNIVERSITY OF PAKISTAN
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR
THE DEGREE OF MASTERS IN BUSINESS ADMINISTRATION
Submitted By
Mc080402262
Sheikh Khurum Akram
Department of Management Sciences,
Virtual University of Pakistan
Acknowledgement In the name of ALLAH, the most Gracious, the most Merciful Firstly I am thankful to ALLAH ALMIGHTY, WHO is sprinkling HIS blessings upon me and my family. HE has bestowed me with sound health and determination to perform this task.
I really acknowledge guidelines from my course tutor who taught me the techniques of research. This project is my own effort.
Executive Summary
I will evaluate three leading pharmaceuticals of Pakistan for profitability ratio analysis of Abbott, Ferozsons and Sanofi-Aventis. I will assess them on the basis of facts and figures provided in their financial statements. My objective is to figure out their flaws and potencies. Outcomes of profitability analysis are worthy for management in making effective decisions. My findings will make easy for all related parties to have impartial analysis.
This project will also make available a snapshot of pharmaceuticals’ capability in managing their resource for yielding profits. The main purpose behind this analysis is to conduct a quantitative study of raw data. Outcomes of my project will assist the title-holders and decision-makers to keep an eye on improvement in their businesses. I will perform profitability ratio analysis of Abbott, Ferozsons and Sanofi-Aventis. I will cite my sources each time if exact quote is copied of an author or paraphrasing of the same is drafted in my own words. I will provide reference if I copy a table, chart, diagram, or graph wholly or partly. Microsoft word and excel will be used
Profitability Ratios’ Analysis of Pharmaceuticals in same industry for FY 2008-10
Sanofi-Aventis
Ferozsons
Abbott
A REPORT
SUBMITTED TO THE DEPARTMENT OF MANAGEMENT SCIENCES,
VIRTUAL UNIVERSITY OF PAKISTAN
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR
THE DEGREE OF MASTERS IN BUSINESS ADMINISTRATION
Submitted By
Mc080402262
Sheikh Khurum Akram
Department of Management Sciences,
Virtual University of Pakistan
Acknowledgement In the name of ALLAH, the most Gracious, the most Merciful Firstly I am thankful to ALLAH ALMIGHTY, WHO is sprinkling HIS blessings upon me and my family. HE has bestowed me with sound health and determination to perform this task.
I really acknowledge guidelines from my course tutor who taught me the techniques of research. This project is my own effort.
Executive Summary
I will evaluate three leading pharmaceuticals of Pakistan for profitability ratio analysis of Abbott, Ferozsons and Sanofi-Aventis. I will assess them on the basis of facts and figures provided in their financial statements. My objective is to figure out their flaws and potencies. Outcomes of profitability analysis are worthy for management in making effective decisions. My findings will make easy for all related parties to have impartial analysis.
This project will also make available a snapshot of pharmaceuticals’ capability in managing their resource for yielding profits. The main purpose behind this analysis is to conduct a quantitative study of raw data. Outcomes of my project will assist the title-holders and decision-makers to keep an eye on improvement in their businesses. I will perform profitability ratio analysis of Abbott, Ferozsons and Sanofi-Aventis. I will cite my sources each time if exact quote is copied of an author or paraphrasing of the same is drafted in my own words. I will provide reference if I copy a table, chart, diagram, or graph wholly or partly. Microsoft word and excel will be used
Bibliography: •Vu hand Outs •Internet sources •www.investopedia.com •http://www.accountingtools.com/fixed-asset-turnover-ratio •http://www.abbott.com.pk/11_Financial.htm •http://www.pakistaneconomist.com/database2/pdffiles/Pharmaceutical/Abbot/Year%202008/ALAnnual-%20Y08.pdf •http://www.ferozsons-labs.com/investor.htm •http://www.sanofi-aventis.com.pk/l/pk/en/layout.jsp?scat=59A5026C-701D-4C54-B1EC-E7788EA00832 •Ross, S.A., R.W. Westerfield and B.D. Jordan. Essentials of Corporate Finance (1999), 2nd Edition, Irwin/McGraw-Hill.